您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMBINATION FORMULATION COMPRISING AMLODIPINE, LOSARTAN AND ROSUVASTATIN
专利权人:
HANMI PHARM. CO.; LTD.
发明人:
IM, HO TAEK,JEONG, MYOUNG KI,KIM, YONG IL,PARK, JAE HYUN,WOO, JONG SOO,CHO. HYUK JUN
申请号:
PH12016500833
公开号:
PH12016500833A1
申请日:
2016.05.05
申请国别(地区):
PH
年份:
2016
代理人:
摘要:
Disclosed is a pharmaceutical combination formulation comprising a first discrete part containing amlodipine and rosuvastatin and a second discrete part containing losartan, which exhibits improved dissolution rate and stability. The inventive combination formulation comprising amlodipine, losartan and rosuvastatin having different action mechanisms from one another can be effectively used to prevent or treat a cardiovascular disorder. Designed to minimize an interaction among active ingredients, the pharmaceutical combination formulation exhibits excellent storage stability and dissolution rates of amlodipine, losartan and rosuvastatin, and thus can be useful in pharmaceutical industries.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充